{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:02:34Z","timestamp":1793332954654,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The activities of EUDF are financially supported by Breakthrough T1D, EASD, EFSD, FEND, IDF Europe, ISPAD, PCDE, SFD, EFPIA, Medtech Europe"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00125-025-06601-5","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:37:59Z","timestamp":1763357879000},"page":"259-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmap"],"prefix":"10.1007","volume":"69","author":[{"given":"Mia","family":"Bajramagic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-4732","authenticated-orcid":false,"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-1627","authenticated-orcid":false,"given":"Mark","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3331-755X","authenticated-orcid":false,"given":"Angus","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Galderisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-1304","authenticated-orcid":false,"given":"Lutz","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6611-8245","authenticated-orcid":false,"given":"Sufyan","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Holm J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8731-7355","authenticated-orcid":false,"given":"Michael","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8082-6560","authenticated-orcid":false,"given":"Neboj\u0161a M.","family":"Lali\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Phillip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Torbeyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4376-6973","authenticated-orcid":false,"given":"Deborah J.","family":"Wake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Zakrzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5388-0270","authenticated-orcid":false,"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"6601_CR1","unstructured":"IDF (2025) IDF diabetes atlas, 11th edn. IDF, Brussels, Belgium"},{"key":"6601_CR2","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1111\/dom.15511","volume":"26","author":"SK Kunutsor","year":"2024","unstructured":"Kunutsor SK, Balasubramanian VG, Zaccardi F et al (2024) Glycaemic control and macrovascular and microvascular outcomes: a systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes. Diabetes Obes Metab 26:2069\u20132081. https:\/\/doi.org\/10.1111\/dom.15511","journal-title":"Diabetes Obes Metab"},{"key":"6601_CR3","doi-asserted-by":"publisher","first-page":"109938","DOI":"10.1016\/j.diabres.2022.109938","volume":"189","author":"A Mesa","year":"2022","unstructured":"Mesa A, Gim\u00e9nez M, Pueyo I et al (2022) Hyperglycemia and hypoglycemia exposure are differentially associated with micro- and macrovascular complications in adults with Type 1 Diabetes. Diabetes Res Clin Pract 189:109938. https:\/\/doi.org\/10.1016\/j.diabres.2022.109938","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"6601_CR4","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3390\/bioengineering10121364","volume":"10","author":"W Ong","year":"2023","unstructured":"Ong W, Liu RW, Makmur A et al (2023) Artificial intelligence applications for osteoporosis classification using computed tomography. Bioengineering 10(12):1364. https:\/\/doi.org\/10.3390\/bioengineering10121364","journal-title":"Bioengineering"},{"issue":"1","key":"6601_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41746-025-01726-8","volume":"8","author":"AY Ong","year":"2025","unstructured":"Ong AY, Taribagil P, Sevgi M et al (2025) A scoping review of artificial intelligence as a medical device for ophthalmic image analysis in Europe, Australia and America. NPJ Digit Med 8(1):323. https:\/\/doi.org\/10.1038\/s41746-025-01726-8","journal-title":"NPJ Digit Med"},{"issue":"1","key":"6601_CR6","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1038\/s41467-023-39631-x","volume":"14","author":"A Pyrros","year":"2023","unstructured":"Pyrros A, Borstelmann SM, Mantravadi R et al (2023) Opportunistic detection of type 2 diabetes using deep learning from frontal chest radiographs. Nat Commun 14(1):4039. https:\/\/doi.org\/10.1038\/s41467-023-39631-x","journal-title":"Nat Commun"},{"key":"6601_CR7","doi-asserted-by":"publisher","first-page":"861062","DOI":"10.3389\/fpubh.2022.861062","volume":"10","author":"O Rabie","year":"2022","unstructured":"Rabie O, Alghazzawi D, Asghar J, Saddozai FK, Asghar MZ (2022) A decision support system for diagnosing diabetes using deep neural network. Front Public Health 10:861062. https:\/\/doi.org\/10.3389\/fpubh.2022.861062","journal-title":"Front Public Health"},{"issue":"11","key":"6601_CR8","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00125-022-05731-4","volume":"65","author":"C Schiborn","year":"2022","unstructured":"Schiborn C, Schulze MB (2022) Precision prognostics for the development of complications in diabetes. Diabetologia 65(11):1867\u20131882. https:\/\/doi.org\/10.1007\/s00125-022-05731-4","journal-title":"Diabetologia"},{"issue":"3","key":"6601_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2105\/ajph.62.3.337","volume":"62","author":"AHV de Ven","year":"1972","unstructured":"de Ven AHV, Delbecq AL (1972) The nominal group as a research instrument for exploratory health studies. Am J Public Health 62(3):337\u2013342. https:\/\/doi.org\/10.2105\/ajph.62.3.337","journal-title":"Am J Public Health"},{"issue":"1","key":"6601_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40271-019-00389-4","volume":"13","author":"D Khodyakov","year":"2020","unstructured":"Khodyakov D, Grant S, Denger B et al (2020) Practical considerations in using online modified-delphi approaches to engage patients and other stakeholders in clinical practice guideline development. Patient 13(1):11\u201321. https:\/\/doi.org\/10.1007\/s40271-019-00389-4","journal-title":"Patient"},{"key":"6601_CR11","doi-asserted-by":"publisher","first-page":"q902","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons KGM, Dhiman P et al (2024) TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385:q902. https:\/\/doi.org\/10.1136\/bmj-2023-078378","journal-title":"BMJ"},{"key":"6601_CR12","doi-asserted-by":"publisher","unstructured":"Deshwal D, Sangwan P (2020) Artificial intelligence for sustainable development: theory, practice and future applications. Stud Comput Intell 101\u2013126. https:\/\/doi.org\/10.1007\/978-3-030-51920-9_7","DOI":"10.1007\/978-3-030-51920-9_7"},{"issue":"11","key":"6601_CR13","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/aje\/kwad107","volume":"192","author":"S Serghiou","year":"2023","unstructured":"Serghiou S, Rough K (2023) Deep learning for epidemiologists: an introduction to neural networks. Am J Epidemiol 192(11):1904\u20131916. https:\/\/doi.org\/10.1093\/aje\/kwad107","journal-title":"Am J Epidemiology"},{"issue":"1","key":"6601_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12874-021-01469-6","volume":"22","author":"CLA Navarro","year":"2022","unstructured":"Navarro CLA, Damen JAA, Takada T et al (2022) Completeness of reporting of clinical prediction models developed using supervised machine learning: a systematic review. BMC Med Res Methodol 22(1):12. https:\/\/doi.org\/10.1186\/s12874-021-01469-6","journal-title":"BMC Med Res Methodol"},{"issue":"9","key":"6601_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/fi15090286","volume":"15","author":"P Zhang","year":"2023","unstructured":"Zhang P, Boulos MNK (2023) Generative AI in medicine and healthcare: promises, opportunities and challenges. Futur Internet 15(9):286. https:\/\/doi.org\/10.3390\/fi15090286","journal-title":"Futur Internet"},{"issue":"7969","key":"6601_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-023-06160-y","volume":"619","author":"LY Jiang","year":"2023","unstructured":"Jiang LY, Liu XC, Nejatian NP et al (2023) Health system-scale language models are all-purpose prediction engines. Nature 619(7969):357\u2013362. https:\/\/doi.org\/10.1038\/s41586-023-06160-y","journal-title":"Nature"},{"issue":"1","key":"6601_CR17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41598-024-84003-0","volume":"15","author":"E Healey","year":"2025","unstructured":"Healey E, Tan ALM, Flint KL, Ruiz JL, Kohane I (2025) A case study on using a large language model to analyze continuous glucose monitoring data. Sci Rep 15(1):1143. https:\/\/doi.org\/10.1038\/s41598-024-84003-0","journal-title":"Sci Rep"},{"key":"6601_CR18","doi-asserted-by":"publisher","first-page":"e58680","DOI":"10.2196\/58680","volume":"9","author":"ER Stevens","year":"2024","unstructured":"Stevens ER, Elmaleh-Sachs A, Lofton H, Mann DM (2024) Lightening the load: generative AI to mitigate the burden of the new era of obesity medical therapy. JMIR Diabetes 9:e58680. https:\/\/doi.org\/10.2196\/58680","journal-title":"JMIR Diabetes"},{"issue":"5","key":"6601_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.scib.2024.01.004","volume":"69","author":"B Sheng","year":"2024","unstructured":"Sheng B, Guan Z, Lim L-L et al (2024) Large language models for diabetes care: potentials and prospects. Sci Bull 69(5):583\u2013588. https:\/\/doi.org\/10.1016\/j.scib.2024.01.004","journal-title":"Sci Bull"},{"key":"6601_CR20","doi-asserted-by":"publisher","first-page":"108737","DOI":"10.1016\/j.cmpb.2025.108737","volume":"265","author":"FJ Lara-Abelenda","year":"2025","unstructured":"Lara-Abelenda FJ, Chushig-Muzo D, Peiro-Corbacho P, W\u00e4gner AM, Granja C, Soguero-Ruiz C (2025) Personalized glucose forecasting for people with type 1 diabetes using large language models. Comput Methods Programs Biomed 265:108737. https:\/\/doi.org\/10.1016\/j.cmpb.2025.108737","journal-title":"Comput Methods Programs Biomed"},{"issue":"3","key":"6601_CR21","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41591-024-03423-7","volume":"31","author":"K Singhal","year":"2025","unstructured":"Singhal K, Tu T, Gottweis J et al (2025) Toward expert-level medical question answering with large language models. Nat Med 31(3):943\u2013950. https:\/\/doi.org\/10.1038\/s41591-024-03423-7","journal-title":"Nat Med"},{"issue":"7972","key":"6601_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41586-023-06291-2","volume":"620","author":"K Singhal","year":"2023","unstructured":"Singhal K, Azizi S, Tu T et al (2023) Large language models encode clinical knowledge. Nature 620(7972):172\u2013180. https:\/\/doi.org\/10.1038\/s41586-023-06291-2","journal-title":"Nature"},{"issue":"6","key":"6601_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/healthcare13060603","volume":"13","author":"J Vrdoljak","year":"2025","unstructured":"Vrdoljak J, Boban Z, Vilovi\u0107 M, Kumri\u0107 M, Bo\u017ei\u0107 J (2025) A review of large language models in medical education, clinical decision support, and healthcare administration. Healthcare 13(6):603. https:\/\/doi.org\/10.3390\/healthcare13060603","journal-title":"Healthcare"},{"issue":"8","key":"6601_CR24","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41591-023-02448-8","volume":"29","author":"AJ Thirunavukarasu","year":"2023","unstructured":"Thirunavukarasu AJ, Ting DSJ, Elangovan K, Gutierrez L, Tan TF, Ting DSW (2023) Large language models in medicine. Nat Med 29(8):1930\u20131940. https:\/\/doi.org\/10.1038\/s41591-023-02448-8","journal-title":"Nat Med"},{"issue":"24","key":"6601_CR25","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/j.jacc.2024.03.401","volume":"83","author":"SS Jain","year":"2024","unstructured":"Jain SS, Elias P, Poterucha T et al (2024) Artificial intelligence in cardiovascular care\u2014part 2: applications JACC review topic of the week. J Am Coll Cardiol 83(24):2487\u20132496. https:\/\/doi.org\/10.1016\/j.jacc.2024.03.401","journal-title":"J Am Coll Cardiol"},{"key":"6601_CR26","first-page":"578","volume":"209","author":"E Lehman","year":"2023","unstructured":"Lehman E, Hernandez E, Mahajan D et al (2023) Do we still need clinical language models? Proc Mach Learn Res 209:578\u2013597","journal-title":"Proc Mach Learn Res"},{"issue":"4","key":"6601_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1177\/19322968241255106","volume":"18","author":"SL Cichosz","year":"2024","unstructured":"Cichosz SL (2024) Enhancing transparency and reporting standards in diabetes prediction modeling: the significance of the TRIPOD+AI 2024 statement. J Diabetes Sci Technol 18(4):989\u2013990. https:\/\/doi.org\/10.1177\/19322968241255106","journal-title":"J Diabetes Sci Technol"},{"key":"6601_CR28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s00125-023-06049-5","volume":"67","author":"J Jendle","year":"2024","unstructured":"Jendle J, Adolfsson P, Choudhary P et al (2024) A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU\/UK\/US perspective. Diabetologia 67:236\u2013245. https:\/\/doi.org\/10.1007\/s00125-023-06049-5","journal-title":"Diabetologia"},{"issue":"5","key":"6601_CR29","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1177\/19322968231178549","volume":"17","author":"JC Espinoza","year":"2023","unstructured":"Espinoza JC, Yeung AM, Huang J, Seley JJ, Longo R, Klonoff DC (2023) The need for data standards and implementation policies to integrate insulin delivery data into the electronic health record. J Diabetes Sci Technol 17(5):1376\u20131386. https:\/\/doi.org\/10.1177\/19322968231178549","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"6601_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2345\/i0899-8205-40-5-375.1","volume":"40","author":"J Kabachinski","year":"2006","unstructured":"Kabachinski J (2006) What is health level 7. Biomed Instrum Technol 40(5):375\u2013379","journal-title":"Biomed Instrum Technol"},{"issue":"1","key":"6601_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12875-024-02282-y","volume":"25","author":"MR Allen","year":"2024","unstructured":"Allen MR, Webb S, Mandvi A, Frieden M, Tai-Seale M, Kallenberg G (2024) Navigating the doctor-patient-AI relationship - a mixed-methods study of physician attitudes toward artificial intelligence in primary care. BMC Prim Care 25(1):42. https:\/\/doi.org\/10.1186\/s12875-024-02282-y","journal-title":"BMC Prim Care"},{"issue":"3","key":"6601_CR32","doi-asserted-by":"publisher","first-page":"e12802","DOI":"10.2196\/12802","volume":"21","author":"C Blease","year":"2019","unstructured":"Blease C, Kaptchuk TJ, Bernstein MH, Mandl KD, Halamka JD, DesRoches CM (2019) Artificial intelligence and the future of primary care: exploratory qualitative study of UK general practitioners\u2019 views. J Med Internet Res 21(3):e12802. https:\/\/doi.org\/10.2196\/12802","journal-title":"J Med Internet Res"},{"issue":"8","key":"6601_CR33","doi-asserted-by":"publisher","DOI":"10.2174\/0115733998276990240117113408","volume":"21","author":"JR Lakey","year":"2025","unstructured":"Lakey JR, Casazza K, Lernhardt W, Mathur EJ, Jenkins I (2025) Machine learning and augmented intelligence enables prognosis of type 2 diabetes prior to clinical manifestation. Curr Diabetes Rev 21(8):e010224226610. https:\/\/doi.org\/10.2174\/0115733998276990240117113408","journal-title":"Curr Diabetes Rev"},{"issue":"9","key":"6601_CR34","doi-asserted-by":"publisher","first-page":"e599","DOI":"10.1016\/s2589-7500(21)00132-1","volume":"3","author":"AT Young","year":"2021","unstructured":"Young AT, Amara D, Bhattacharya A, Wei ML (2021) Patient and general public attitudes towards clinical artificial intelligence: a mixed methods systematic review. Lancet Digit Health 3(9):e599\u2013e611. https:\/\/doi.org\/10.1016\/s2589-7500(21)00132-1","journal-title":"Lancet Digit Health"},{"issue":"1","key":"6601_CR35","doi-asserted-by":"publisher","first-page":"e100450","DOI":"10.1136\/bmjhci-2021-100450","volume":"28","author":"IA Scott","year":"2021","unstructured":"Scott IA, Carter SM, Coiera E (2021) Exploring stakeholder attitudes towards AI in clinical practice. BMJ Health Care Inform 28(1):e100450. https:\/\/doi.org\/10.1136\/bmjhci-2021-100450","journal-title":"BMJ Health Care Inform"},{"issue":"1","key":"6601_CR36","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/dci20-0053","volume":"44","author":"F Hill-Briggs","year":"2020","unstructured":"Hill-Briggs F, Adler NE, Berkowitz SA et al (2020) Social determinants of health and diabetes: a scientific review. Diabetes Care 44(1):258\u2013279. https:\/\/doi.org\/10.2337\/dci20-0053","journal-title":"Diabetes Care"},{"issue":"1","key":"6601_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2337\/dci20-0060","volume":"44","author":"SM Ogunwole","year":"2021","unstructured":"Ogunwole SM, Golden SH (2021) Social determinants of health and structural inequities\u2014root causes of diabetes disparities. Diabetes Care 44(1):11\u201313. https:\/\/doi.org\/10.2337\/dci20-0060","journal-title":"Diabetes Care"},{"issue":"4","key":"6601_CR38","doi-asserted-by":"publisher","first-page":"e15024","DOI":"10.1111\/dme.15024","volume":"40","author":"J Chan","year":"2023","unstructured":"Chan J, Blane D, Choudhary P et al (2023) Addressing health inequalities in diabetes through research: recommendations from diabetes UK\u2019s 2022 health inequalities in diabetes workshop. Diabet Med 40(4):e15024. https:\/\/doi.org\/10.1111\/dme.15024","journal-title":"Diabet Med"},{"issue":"1","key":"6601_CR39","doi-asserted-by":"publisher","first-page":"100341","DOI":"10.1016\/j.infoandorg.2021.100341","volume":"31","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Walsham G (2021) Inequality of what? An intersectional approach to digital inequality under Covid-19. Inf Organ 31(1):100341. https:\/\/doi.org\/10.1016\/j.infoandorg.2021.100341","journal-title":"Inf Organ"},{"key":"6601_CR40","doi-asserted-by":"publisher","unstructured":"Mubarak F, Suomi R (2022) Elderly forgotten? Digital exclusion in the information age and the rising grey digital divide. Inquiry 59:00469580221096272. https:\/\/doi.org\/10.1177\/00469580221096272","DOI":"10.1177\/00469580221096272"},{"issue":"4","key":"6601_CR41","doi-asserted-by":"publisher","first-page":"e003424","DOI":"10.1136\/bmjdrc-2023-003424","volume":"11","author":"CR Cleland","year":"2023","unstructured":"Cleland CR, Rwiza J, Evans JR et al (2023) Artificial intelligence for diabetic retinopathy in low-income and middle-income countries: a scoping review. BMJ Open Diabetes Res Care 11(4):e003424. https:\/\/doi.org\/10.1136\/bmjdrc-2023-003424","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"4","key":"6601_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000546713","volume":"98","author":"R Nimri","year":"2025","unstructured":"Nimri R, Phillip M (2025) Enhancing care in type 1 diabetes with artificial intelligence driven clinical decision support systems. Horm Res Paediatr 98(4):384\u2013395. https:\/\/doi.org\/10.1159\/000546713","journal-title":"Horm Res Paediatr"},{"key":"6601_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41746-018-0040-6","volume":"1","author":"MD Abr\u00e0moff","year":"2018","unstructured":"Abr\u00e0moff MD, Lavin PT, Birch M, Shah N, Folk JC (2018) Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med 1:39. https:\/\/doi.org\/10.1038\/s41746-018-0040-6","journal-title":"NPJ Digit Med"},{"issue":"10","key":"6601_CR44","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.2337\/dci23-0032","volume":"46","author":"AE Rajesh","year":"2023","unstructured":"Rajesh AE, Davidson OQ, Lee CS, Lee AY (2023) Artificial intelligence and diabetic retinopathy: AI framework, prospective studies, head-to-head validation, and cost-effectiveness. Diabetes Care 46(10):1728\u20131739. https:\/\/doi.org\/10.2337\/dci23-0032","journal-title":"Diabetes Care"},{"issue":"12","key":"6601_CR45","doi-asserted-by":"publisher","first-page":"e2340232","DOI":"10.1001\/jamanetworkopen.2023.40232","volume":"6","author":"A Nayak","year":"2023","unstructured":"Nayak A, Vakili S, Nayak K et al (2023) Use of voice-based conversational artificial intelligence for basal insulin prescription management among patients with type 2 diabetes. JAMA Netw Open 6(12):e2340232. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.40232","journal-title":"JAMA Netw Open"},{"issue":"Suppl 1","key":"6601_CR46","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1055\/s-0041-1728757","volume":"60","author":"S Tarumi","year":"2021","unstructured":"Tarumi S, Takeuchi W, Chalkidis G et al (2021) Leveraging artificial intelligence to improve chronic disease care: methods and application to pharmacotherapy decision support for type-2 diabetes mellitus. Methods Inf Med 60(Suppl 1):e32\u2013e43. https:\/\/doi.org\/10.1055\/s-0041-1728757","journal-title":"Methods Inf Med"},{"issue":"10480","key":"6601_CR47","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/s0140-6736(24)02617-5","volume":"405","author":"JM Dennis","year":"2025","unstructured":"Dennis JM, Young KG, Cardoso P et al (2025) A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study. Lancet 405(10480):701\u2013714. https:\/\/doi.org\/10.1016\/s0140-6736(24)02617-5","journal-title":"Lancet"},{"issue":"2","key":"6601_CR48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00125-019-05034-1","volume":"63","author":"GA Fleming","year":"2020","unstructured":"Fleming GA, Petrie JR, Bergenstal RM, Holl RW, Peters AL, Heinemann L (2020) Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia 63(2):229\u2013241. https:\/\/doi.org\/10.1007\/s00125-019-05034-1","journal-title":"Diabetologia"},{"issue":"5","key":"6601_CR49","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2337\/dc22-1929","volume":"46","author":"Y-B Lee","year":"2023","unstructured":"Lee Y-B, Kim G, Jun JE et al (2023) An integrated digital health care platform for diabetes management with AI-based dietary management: 48-week results from a randomized controlled trial. Diabetes Care 46(5):959\u2013966. https:\/\/doi.org\/10.2337\/dc22-1929","journal-title":"Diabetes Care"},{"key":"6601_CR50","doi-asserted-by":"publisher","unstructured":"Baumgartner M, Kuhn C, Nakas CT, Herzig D, Bally L (2024) Carbohydrate estimation accuracy of two commercially available smartphone applications vs estimation by individuals with type 1 diabetes: a comparative study. J Diabetes Sci Technol 19322968241264744. https:\/\/doi.org\/10.1177\/19322968241264744","DOI":"10.1177\/19322968241264744"},{"issue":"5","key":"6601_CR51","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.2196\/jmir.5567","volume":"18","author":"D Rhyner","year":"2016","unstructured":"Rhyner D, Loher H, Dehais J et al (2016) Carbohydrate estimation by a mobile phone-based system versus self-estimations of individuals with type 1 diabetes mellitus: a comparative study. J Med Internet Res 18(5):e101. https:\/\/doi.org\/10.2196\/jmir.5567","journal-title":"J Med Internet Res"},{"issue":"2","key":"6601_CR52","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2337\/dc12-0080","volume":"36","author":"D Cooke","year":"2013","unstructured":"Cooke D, Bond R, Lawton J et al (2013) Structured type 1 diabetes education delivered within routine care. Diabetes Care 36(2):270\u2013272. https:\/\/doi.org\/10.2337\/dc12-0080","journal-title":"Diabetes Care"},{"issue":"6","key":"6601_CR53","doi-asserted-by":"publisher","first-page":"e3840","DOI":"10.1002\/dmrr.3840","volume":"40","author":"DS Romadlon","year":"2024","unstructured":"Romadlon DS, Tu Y, Chen Y, Hasan F, Kurniawan R, Chiu H (2024) Comparative effects of diabetes self-management programs on type 2 diabetes clinical outcomes: a systematic review and network meta-analysis. Diabetes Metab Res Rev 40(6):e3840. https:\/\/doi.org\/10.1002\/dmrr.3840","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"6601_CR54","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/dia.2023.0134","volume":"25","author":"A Nakhleh","year":"2023","unstructured":"Nakhleh A, Spitzer S, Shehadeh N (2023) ChatGPT\u2019s response to the diabetes knowledge questionnaire: implications for diabetes education. Diabetes Technol Ther 25(8):571\u2013573. https:\/\/doi.org\/10.1089\/dia.2023.0134","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"6601_CR55","doi-asserted-by":"publisher","first-page":"e38784","DOI":"10.7759\/cureus.38784","volume":"15","author":"E Hamed","year":"2023","unstructured":"Hamed E, Eid A, Alberry M (2023) Exploring ChatGPT\u2019s potential in facilitating adaptation of clinical guidelines: a case study of diabetic ketoacidosis guidelines. Cureus 15(5):e38784. https:\/\/doi.org\/10.7759\/cureus.38784","journal-title":"Cureus"},{"issue":"5","key":"6601_CR56","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.2337\/dc23-0197","volume":"46","author":"GGR Sng","year":"2023","unstructured":"Sng GGR, Tung JYM, Lim DYZ, Bee YM (2023) Potential and pitfalls of ChatGPT and natural-language artificial intelligence models for diabetes education. Diabetes Care 46(5):e103\u2013e105. https:\/\/doi.org\/10.2337\/dc23-0197","journal-title":"Diabetes Care"},{"issue":"1","key":"6601_CR57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s44163-021-00005-1","volume":"1","author":"F Alloatti","year":"2021","unstructured":"Alloatti F, Bosca A, Caro LD, Pieraccini F (2021) Diabetes and conversational agents: the AIDA project case study. Discov Artif Intell 1(1):4. https:\/\/doi.org\/10.1007\/s44163-021-00005-1","journal-title":"Discov Artif Intell"},{"issue":"1","key":"6601_CR58","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/19322968231178020","volume":"19","author":"CM Nassar","year":"2025","unstructured":"Nassar CM, Dunlea R, Montero A, Tweedt A, Magee MF (2025) Feasibility and preliminary behavioral and clinical efficacy of a diabetes education Chatbot pilot among adults with type 2 diabetes. J Diabetes Sci Technol 19(1):54\u201362. https:\/\/doi.org\/10.1177\/19322968231178020","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"6601_CR59","doi-asserted-by":"publisher","first-page":"e38380","DOI":"10.7759\/cureus.38380","volume":"15","author":"S Sharma","year":"2023","unstructured":"Sharma S, Pajai S, Prasad R et al (2023) A critical review of ChatGPT as a potential substitute for diabetes educators. Cureus 15(5):e38380. https:\/\/doi.org\/10.7759\/cureus.38380","journal-title":"Cureus"},{"key":"6601_CR60","doi-asserted-by":"publisher","first-page":"205520762211287","DOI":"10.1177\/20552076221128677","volume":"9","author":"C Gardner","year":"2023","unstructured":"Gardner C, Wake D, Brodie D et al (2023) Evaluation of prototype risk prediction tools for clinicians and people living with type 2 diabetes in North West London using the think aloud method. Digit Health 9:2055207622112877. https:\/\/doi.org\/10.1177\/20552076221128677","journal-title":"Digit Health"},{"key":"6601_CR61","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3233\/shti210321","volume":"281","author":"D Glachs","year":"2021","unstructured":"Glachs D, Namli T, Strohmeier F et al (2021) A predictive model-based decision support system for diabetes patient empowerment. Stud Health Technol Inform 281:963\u2013968. https:\/\/doi.org\/10.3233\/shti210321","journal-title":"Stud Health Technol Inform"},{"issue":"3","key":"6601_CR62","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/19322968211069172","volume":"17","author":"SG Cunningham","year":"2023","unstructured":"Cunningham SG, Stoddart A, Wild SH, Conway NJ, Gray AM, Wake DJ (2023) Cost-utility of an online education platform and diabetes personal health record: analysis over ten years. J Diabetes Sci Technol 17(3):715\u2013726. https:\/\/doi.org\/10.1177\/19322968211069172","journal-title":"J Diabetes Sci Technol"},{"issue":"9","key":"6601_CR63","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41591-020-1045-7","volume":"26","author":"R Nimri","year":"2020","unstructured":"Nimri R, Battelino T, Laffel LM et al (2020) Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes. Nat Med 26(9):1380\u20131384. https:\/\/doi.org\/10.1038\/s41591-020-1045-7","journal-title":"Nat Med"},{"issue":"2","key":"6601_CR64","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/1932296819867686","volume":"14","author":"L Heinemann","year":"2020","unstructured":"Heinemann L, Schramm W, Koenig H et al (2020) Benefit of digital tools used for integrated personalized diabetes management: results from the PDM-ProValue study program. J Diabetes Sci Technol 14(2):240\u2013249. https:\/\/doi.org\/10.1177\/1932296819867686","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"6601_CR65","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12916-024-03393-0","volume":"22","author":"H Gudjonsdottir","year":"2024","unstructured":"Gudjonsdottir H, Tynelius P, Stattin NS, M\u00e9ndez DY, Lager A, Brynedal B (2024) Undiagnosed type 2 diabetes is common \u2013 intensified screening of established risk groups is imperative in Sweden: the SDPP cohort. BMC Med 22(1):168. https:\/\/doi.org\/10.1186\/s12916-024-03393-0","journal-title":"BMC Med"},{"key":"6601_CR66","doi-asserted-by":"publisher","unstructured":"Lutsker G, Sapir G, Shilo S et al (2025) From glucose patterns to health outcomes: a generalizable foundation model for continuous glucose monitor data analysis. arXiv (Preprint). 7 Jan 2025. Available from: https:\/\/doi.org\/10.48550\/arxiv.2408.11876","DOI":"10.48550\/arxiv.2408.11876"},{"issue":"6","key":"6601_CR67","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00125-024-06089-5","volume":"67","author":"PF Teixeira","year":"2024","unstructured":"Teixeira PF, Battelino T, Carlsson A et al (2024) Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data. Diabetologia 67(6):985\u2013994. https:\/\/doi.org\/10.1007\/s00125-024-06089-5","journal-title":"Diabetologia"},{"issue":"10","key":"6601_CR68","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2337\/dc21-2612","volume":"45","author":"JP Krischer","year":"2022","unstructured":"Krischer JP, Liu X, Lernmark \u00c5 et al (2022) Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: the TEDDY study. Diabetes Care 45(10):2271\u20132281. https:\/\/doi.org\/10.2337\/dc21-2612","journal-title":"Diabetes Care"},{"issue":"3","key":"6601_CR69","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/s2589-7500(20)30292-2","volume":"3","author":"UJ Muehlematter","year":"2021","unstructured":"Muehlematter UJ, Daniore P, Vokinger KN (2021) Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015\u201320): a comparative analysis. Lancet Digit Health 3(3):e195\u2013e203. https:\/\/doi.org\/10.1016\/s2589-7500(20)30292-2","journal-title":"Lancet Digit Health"},{"issue":"4","key":"6601_CR70","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41591-021-01312-x","volume":"27","author":"E Wu","year":"2021","unstructured":"Wu E, Wu K, Daneshjou R, Ouyang D, Ho DE, Zou J (2021) How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals. Nat Med 27(4):582\u2013584. https:\/\/doi.org\/10.1038\/s41591-021-01312-x","journal-title":"Nat Med"},{"issue":"3","key":"6601_CR71","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/dom.16153","volume":"27","author":"C Mathieu","year":"2025","unstructured":"Mathieu C, Irace C, Wilmot EG et al (2025) Minimum expectations for market authorization of continuous glucose monitoring devices in Europe\u2014\u2018eCGM\u2019 compliance status. Diabetes Obes Metab 27(3):1025\u20131031. https:\/\/doi.org\/10.1111\/dom.16153","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"6601_CR72","doi-asserted-by":"publisher","first-page":"e0001556","DOI":"10.1371\/journal.pgph.0001556","volume":"3","author":"HT Cronj\u00e9","year":"2023","unstructured":"Cronj\u00e9 HT, Katsiferis A, Elsenburg LK et al (2023) Assessing racial bias in type 2 diabetes risk prediction algorithms. PLOS Glob Public Health 3(5):e0001556. https:\/\/doi.org\/10.1371\/journal.pgph.0001556","journal-title":"PLOS Glob Public Health"},{"issue":"6464","key":"6601_CR73","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1126\/science.aax2342","volume":"366","author":"Z Obermeyer","year":"2019","unstructured":"Obermeyer Z, Powers B, Vogeli C, Mullainathan S (2019) Dissecting racial bias in an algorithm used to manage the health of populations. Science 366(6464):447\u2013453. https:\/\/doi.org\/10.1126\/science.aax2342","journal-title":"Science"},{"key":"6601_CR74","unstructured":"Medicines and Healthcare products Regulatory Agency (2021) Good machine learning practice for medical device development: guiding principles. Available from: https:\/\/www.gov.uk\/government\/publications\/good-machine-learning-practice-for-medical-device-development-guiding-principles. Accessed: 5 Sep 2025"},{"key":"6601_CR75","unstructured":"Kenyon T (2022) AI3C: Accelerating AI innovation in the healthcare industry. Available from: https:\/\/aimagazine.com\/ai-strategy\/ai3c-accelerating-ai-innovation-healthcare-industry. Accessed: 5 Sep 2025"},{"key":"6601_CR76","unstructured":"European Commission (2022) Proposal for a Regulation of the European Parliament and of the Council on the European Health Data Space COM\/2022\/197 Final. Available from: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex:52022PC0197. Accessed: 5 Sep 2025"},{"issue":"8","key":"6601_CR77","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/dmcn.16359","volume":"67","author":"SD Broe","year":"2025","unstructured":"Broe SD, Marly N (2025) The European Health Data Space: unlocking the power of health data. Dev Med Child Neurol 67(8):969\u2013970. https:\/\/doi.org\/10.1111\/dmcn.16359","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"6601_CR78","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1109\/mci.2021.3129960","volume":"17","author":"R Hamon","year":"2022","unstructured":"Hamon R, Junklewitz H, Sanchez I, Malgieri G, Hert PD (2022) Bridging the gap between AI and explainability in the GDPR: towards trustworthiness-by-design in automated decision-making. IEEE Comput Intell Mag 17(1):72\u201385. https:\/\/doi.org\/10.1109\/mci.2021.3129960","journal-title":"IEEE Comput Intell Mag"},{"key":"6601_CR79","doi-asserted-by":"publisher","unstructured":"Schaarup JFR, Aggarwal R, Dalsgaard E-M et al (2023) Perception of artificial intelligence-based solutions in healthcare among people with and without diabetes: a cross-sectional survey from the health in Central Denmark cohort. Diabetes Epidemiol Manag 9. https:\/\/doi.org\/10.1016\/j.deman.2022.100114","DOI":"10.1016\/j.deman.2022.100114"},{"issue":"5","key":"6601_CR80","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2337\/dci23-0009","volume":"46","author":"AR Kahkoska","year":"2023","unstructured":"Kahkoska AR, Sarteau AC, Crowley MJ (2023) Delivering on the promise of technology to augment behavioral interventions in type 2 diabetes. Diabetes Care 46(5):918\u2013920. https:\/\/doi.org\/10.2337\/dci23-0009","journal-title":"Diabetes Care"},{"issue":"1","key":"6601_CR81","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41746-019-0132-y","volume":"2","author":"V-T Tran","year":"2019","unstructured":"Tran V-T, Riveros C, Ravaud P (2019) Patients\u2019 views of wearable devices and AI in healthcare: findings from the ComPaRe e-cohort. NPJ Digit Med 2(1):53. https:\/\/doi.org\/10.1038\/s41746-019-0132-y","journal-title":"NPJ Digit Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06601-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:03:06Z","timestamp":1767823386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06601-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["6601"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06601-5","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We thank the European Diabetes Forum (EUDF) for inviting and organising the working group and for providing funding to Robert Brines (Bite Medical Consulting, Cambridge, UK), who supported the working group by collating and compiling author revisions during the manuscript drafting process. Thanks are also extended to the following EUDF member organisations\u2014Breakthrough T1D, EASD, European Foundation for the Study of Diabetes (EFSD), Foundation of European Nurses in Diabetes (FEND), IDF Europe, International Society for Pediatric and Adolescent Diabetes (ISPAD), Primary Care Diabetes Europe (PCDE) and Swedish Association for Diabetology (SFD)\u2014and to the EUDF supporting collaborators European Federation of Pharmaceutical Industries and Associations (EFPIA) and Medtech Europe","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"Any data generated during and\/or analysed in the current document are available from the corresponding author on reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The activities of the EUDF are financially supported by Breakthrough T1D, EASD, EFSD, FEND, IDF Europe, ISPAD, PCDE, SFD, EFPIA and Medtech Europe.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"TB is funded in part by the Slovenian Research and Innovation Agency (grant no. P3-0343). MJ declares consultant and\/or speaker fees and\/or research support from Abbott, Air Liquide Sante\u0301 International, Amgen, Asdia, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Dexcom, Dinno Sante\u0301, Glooko, Insulet, LifeScan, Lilly, LVL M\u00e9dical, Medtronic, MSD, Nestle HomeCare, Novo Nordisk, Organon, Orkyn, Roche Diabetes, Sanofi, Tandem, Vitalaire, Voluntis and Ypsomed. SDP has served as president of the EASD\/European Foundation for the Study of Diabetes (EFSD) (2020\u20132022) and is the president of the EUDF and the Menarini Foundation; has received research grants to his institution from AstraZeneca and Boehringer Ingelheim; has served as advisor for Abbott, Amarin Corporation, Amplitude, Applied Therapeutics, AstraZeneca, Biomea Fusion, Eli Lilly, EvaPharma, Menarini International, Novo Nordisk, Sanofi and Sun Pharmaceuticals; and has received fees for speaking from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Laboratori Guidotti, Menarini International, Merck Sharpe & Dohme and Novo Nordisk. LH is a consultant for Abbott, embecta, Lifecare, Medtronic, Dexcom, Roche Diagnostics, Liom and Perfood. He is part owner of the Profil Institut f\u00fcr Stoffwechselforschung in Neuss, Germany; Science Consulting in Diabetes GmbH, D\u00fcsseldorf, Germany; and diateam GmbH, Bad Mergentheim, Germany. SH is funded in part by the Medical Research Council Clinical Academic Partnership award (MR\/W030004\/1). SH has served on the advisory board for Tandem, Dexcom, Medtronic, Sanofi and Vertex and undertaken non-promotional educational and\/or consultancy work for Abbott UK, Insulet, Dexcom and Roche, and SH\u2019s institution has received research grant support from Abbott and Insulet. MP reports advisory board membership for Mannkind, Medtronic Diabetes, Pfizer, Sanofi, LifeScan, Novo Nordisk, Insulet, ProventionBio, Merck, Ascensia, Bayer, embecta and Tandem; consulting fees for Qulab Medical, ProventionBio and Domp\u00e9; and speaker fees for Sanofi. MP has also received research grants from Eli Lilly, Medtronic Diabetes, Novo Nordisk, Pfizer, Sanofi, DreaMed Diabetes, NG Solutions, Domp\u00e9, Lumos, Gwave, OPKO, ProventionBio and AstraZeneca, and reports stock ownership in DreaMed Diabetes and NG Solutions. PS is president of the IDF. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"The aims and focus of this article were conceived by SDP, BT and TB and developed with the wider working group, who comprise the authorship of the article. All authors meet the ICMJE criteria for authorship for this article, take responsibility for the integrity of the work as a whole, have reviewed the article critically for intellectual content and have given their final approval for this version to be published. SDP is the guarantor of this work and takes full responsibility for the integrity of the evidence-based discussion and the development of the consensus recommendations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}